Perrigo Ordinary Shares reported $112.7M in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US USD 2.17B 316M
Abbvie ABBV:US USD 7.41B 84M
Catalent CTLT:US USD 167M 111M
Coherus Biosciences CHRS:US USD -58870000 27.78M
Corcept Therapeutics CORT:US USD 24.28M 8.73M
Dr.Reddys Laboratories DRRD:IN INR 16.51B 350M
Eli Lilly And LLY:US USD 2.04B 38.3M
Horizon Pharma HZNP:US USD 340.7M 25.6M
JAZZ PHA JAZZ:US USD -46767000 464.14M
Johnson & Johnson JNJ:US USD 7.42B 655M
Merk MRK:US USD 4.89B 560M
Nestle NESN:VX 8.12B 792M
Pacira Pharmaceuticals PCRX:US USD 46.48M 4.25M
Perrigo Ordinary Shares PRGO:US USD 112.7M 16M
Pfizer PFE:US USD 7.38B 3.3B
Prestige Brands PBH:US USD 68.12M 1.52M
Sanofi SAN:FP EUR 2.75B 1.68B
Supernus Pharmaceuticals SUPN:US USD 35.14M 35.58M
Teva Pharmaceutical TEVA:IT USD -1100000000 1.87B
Xeris Pharmaceuticals Inc XERS:US USD -13268000 8.9M
Zoetis ZTS:US USD 679M 35M